Azenta Life Sciences

Beyond the Freezing Point: The Science of Biopharmaceutical Preservation

How Cooling Rate Affects Crystallization Freezing is widely used to preserve biopharmaceuticals, but maintaining stability involves more than simply keeping products below 0°C. The rate of cooling, the behavior of dissolved excipients, and the temperature at which formulations become fully…

Lab Chemical Relocation: Hidden Risks and How to Avoid Them

Lab chemical relocation is common when facilities expand or research operations consolidate and can even be a routine step in a multi-site pharmaceutical workflow. The process may seem straightforward at first glance, but it’s more challenging than simply moving bottles from origin to destination.…

Cell and Gene Therapy at an Inflection Point: From Scientific Breakthrough to Sustainable Delivery

Part 31 of our Bridging the Gap Series (Summary of the webinar session held in June 2026) For much of the past two decades, the cell and gene therapy industry has been defined by scientific possibility. Researchers demonstrated that engineered cells could eliminate previously untreatable cancers.…

Why Biological Material Lab Relocation Requires Much More Than Boxes and a Moving Truck

When moving a laboratory from one location to another, you may be tempted to hire one moving company for the entire project. Desks and chairs, mass spectrometers and cryogenic freezers, stem cells and fibroblasts, all packed in the same truck. That should make things less complicated, right? Wrong.…

Lessons from CTMC: Rethinking the Infrastructure Behind Cell Therapy Innovation

Part 30 of our Bridging the Gap Series (Summary of the webinar session held in May 2026) For all the momentum in cell and gene therapy, one challenge continues to define the field: how to move breakthrough science into patients faster, more efficiently, and at meaningful scale. Over the past…

Foundational Strategies That Can Shave Months Off Your Clinical Program: Biorepositories

Part 2 of our Strategies to Speed Clinical Trials Series The path from therapeutic discovery to regulatory approval remains long, with significant time devoted to clinical testing. When investing up to 15 years or more in a potential therapeutic, with much of that time dedicated to clinical…